Skip to main navigation Contact Us Please submit your question using the form below. * Indicates required field Name Email Subject Comments Email Alerts RSS Print Share Search ABOUT PRODUCT SCIENCE PORTFOLIO ONGOING STUDIES CAREERS CONTACT © 2021 Dynavax Technologies. All rights reserved. Website Design: Hane Chow, Inc.

Developing vaccines based on cutting-edge Toll-Like Receptor (TLR) biology. Ongoing Studies We have a number of ongoing post marketing and investigational studies. DV2-HBV-25 (POST-MARKETING STUDY FOR ACUTE MYOCARDIAL INFARCTION EVENTS) DV2-HBV-26 (POST-MARKETING STUDY FOR IMMUNE-MEDIATED, HERPES ZOSTER, AND ANAPHYLAXIS EVENTS) DV2-HBV-27 (PREGNANCY REGISTRY) DV2-HBV-24 (END-STAGE RENAL DISEASE) ONGOING STUDIES LISTING Partnership Transforming the treatment of life-threatening diseases requires a science-driven approach, a dynamic team, and constant innovation. If you are of the same mindset and would like to collaborate with Dynavax, contact our business development department. CONTACT businessdev@dynavax.com CAREERS CONTACT TERMS OF USE PRIVACY NOTICE © 2021 Dynavax Technologies. All rights reserved. Website Design: Hane Chow, Inc. US-19-00-00200